Harbin Gloria Pharmaceuticals Capital Reinvestment Ratio
Harbin Gloria Pharmaceuticals capital reinvestment ratio. Harbin Gloria Pharmaceuticals (002437) has a Capital Reinvestment Ratio of 0.02x as of September 2025, meaning it reinvests 0% of its operating cash flow (CN¥182.89 Million) in capital expenditures (CN¥4.26 Million). Check how aggressively does Harbin Gloria Pharmaceuticals reinvest cash to assess the company's total reinvestment commitment from operating cash flow.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of Harbin Gloria Pharmaceuticals (2007–2025)
Capital reinvestment ratio of Harbin Gloria Pharmaceuticals from 2007 to 2025. This chart tracks Harbin Gloria Pharmaceuticals's Capital Reinvestment Ratio across 19 annual periods. Also explore Harbin Gloria Pharmaceuticals (002437) net asset momentum to track the company's year-over-year net asset growth rate.
Harbin Gloria Pharmaceuticals Capital Reinvestment Ratio by Year (2007–2025)
Harbin Gloria Pharmaceuticals capital reinvestment ratio by year from 2007 to 2025. For the full cash flow conversion analysis, see 002437 cash flow metrics.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.09x | CN¥273.36 Million | CN¥23.81 Million | ▼ -43.1% |
| 2024 | 0.15x | CN¥410.94 Million | CN¥62.90 Million | ▲ +41.7% |
| 2023 | 0.11x | CN¥274.18 Million | CN¥29.62 Million | ▼ -14.4% |
| 2022 | 0.13x | CN¥261.62 Million | CN¥33.01 Million | ▲ +0.3% |
| 2021 | 0.13x | CN¥274.18 Million | CN¥34.51 Million | ▼ -96.3% |
| 2020 | 3.42x | CN¥12.76 Million | CN¥43.66 Million | ▲ +4211.5% |
| 2019 | 0.08x | CN¥610.37 Million | CN¥48.43 Million | ▼ -11.6% |
| 2018 | 0.09x | CN¥1.16 Billion | CN¥104.34 Million | ▼ -69.9% |
| 2017 | 0.30x | CN¥651.80 Million | CN¥194.63 Million | ▲ +67.6% |
| 2016 | 0.18x | CN¥1.04 Billion | CN¥185.34 Million | ▼ -55.8% |
| 2015 | 0.40x | CN¥702.05 Million | CN¥283.10 Million | ▲ +115.9% |
| 2014 | 0.19x | CN¥674.04 Million | CN¥125.89 Million | ▼ -48.2% |
| 2013 | 0.36x | CN¥453.02 Million | CN¥163.35 Million | ▼ -48.6% |
| 2012 | 0.70x | CN¥205.89 Million | CN¥144.37 Million | ▼ -46.0% |
| 2011 | 1.30x | CN¥128.61 Million | CN¥166.90 Million | ▼ -39.3% |
| 2010 | 2.14x | CN¥112.59 Million | CN¥240.88 Million | ▲ +494.5% |
| 2009 | 0.36x | CN¥170.82 Million | CN¥61.47 Million | ▼ -45.4% |
| 2008 | 0.66x | CN¥57.81 Million | CN¥38.08 Million | ▲ +161.3% |
| 2007 | 0.25x | CN¥52.26 Million | CN¥13.17 Million | — |